Published in BMJ Open on July 02, 2012
PC4PrEP: Integrating PrEP Into Primary Care (PC4PrEP) | NCT03617874
The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med (2013) 1.98
Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS One (2013) 1.17
Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations. AIDS Res Hum Retroviruses (2013) 0.95
Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru. AIDS Res Hum Retroviruses (2014) 0.92
Getting PrEPared for HIV Prevention Navigation: Young Black Gay Men Talk About HIV Prevention in the Biomedical Era. AIDS Patient Care STDS (2015) 0.90
How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores". Am J Public Health (2015) 0.87
Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP. J Acquir Immune Defic Syndr (2015) 0.87
'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response. Addiction (2016) 0.78
Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature. AIDS Behav (2016) 0.78
Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from Diminishing Public Support. AIDS Behav (2016) 0.77
Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America. J Int AIDS Soc (2016) 0.75
Preexposure Prophylaxis of HIV Infection: the Role of Clinical Practices in Ending the HIV Epidemic. Curr HIV/AIDS Rep (2017) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19
Qualitative research in health care. Analysing qualitative data. BMJ (2000) 34.13
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet (2008) 7.42
Papers that go beyond numbers (qualitative research) BMJ (1997) 5.48
Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet (2011) 5.34
The history and challenge of HIV prevention. Lancet (2008) 3.34
Coming to terms with complexity: a call to action for HIV prevention. Lancet (2008) 3.15
Making HIV prevention programmes work. Lancet (2008) 2.22
Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One (2012) 2.09
The stigma of being HIV-positive in Africa. PLoS Med (2005) 1.98
Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep (2010) 1.90
Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings. AIDS Patient Care STDS (2011) 1.60
Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS Behav (2011) 1.43
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities. J Int AIDS Soc (2010) 1.35
Evaluation of large-scale combination HIV prevention programs: essential issues. J Acquir Immune Defic Syndr (2011) 1.32
Challenges to microbicide introduction in South Africa. Soc Sci Med (2006) 1.27
Blame, symbolic stigma and HIV misconceptions are associated with support for coercive measures in urban India. AIDS Behav (2012) 1.15
Microbicide acceptability: insights for future directions from providers and policy makers. AIDS Educ Prev (2008) 0.91
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84
Medicine. The need for a global HIV vaccine enterprise. Science (2003) 4.70
UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet (2011) 3.68
The Ebola emergency--immediate action, ongoing strategy. N Engl J Med (2014) 2.80
Prevalence, awareness, treatment and control of hypertension among slum dwellers in Nairobi, Kenya. J Hypertens (2013) 2.32
Combination HIV prevention. Lancet (2008) 2.10
Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One (2012) 2.09
Improving responsiveness of health systems to non-communicable diseases. Lancet (2013) 2.06
The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS (2013) 1.81
Infectious disease: tough choices to reduce Ebola transmission. Nature (2014) 1.77
Engaging men in prevention and care for HIV/AIDS in Africa. PLoS Med (2012) 1.71
Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? PLoS Med (2013) 1.67
Prevention and control of chronic diseases. BMJ (2010) 1.56
Human immunodeficiency virus infection and other sexually transmitted diseases in developing countries: public health importance and priorities for resource allocation. J Infect Dis (1996) 1.44
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities. J Int AIDS Soc (2010) 1.35
Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis. PLoS One (2013) 1.28
Redesigning the AIDS response for long-term impact. Bull World Health Organ (2011) 1.17
Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS One (2013) 1.17
Modular psychotherapy for anxiety in older primary care patients. Am J Geriatr Psychiatry (2009) 1.16
The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review. Curr Opin HIV AIDS (2013) 1.14
Interview with Peter Piot. Interview by Marc Vandenbruaene. Sex Transm Infect (2007) 1.09
Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria. J Hypertens (2015) 1.04
Chronic kidney disease: a new priority for primary care. Br J Gen Pract (2006) 1.03
Scientific evidence alone is not sufficient basis for health policy. BMJ (2012) 1.00
Global public health leadership for the twenty-first century: towards improved health of all populations. Glob Public Health (2012) 0.96
GBD 2.0: a continuously updated global resource. Lancet (2013) 0.96
Do support groups members disclose less to their partners? The dynamics of HIV disclosure in four African countries. BMC Public Health (2013) 0.90
A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda. PLoS One (2010) 0.89
Setting new standards for targeted HIV prevention: the Avahan initiative in India. Sex Transm Infect (2010) 0.89
Health system strengthening in Myanmar during political reforms: perspectives from international agencies. Health Policy Plan (2014) 0.87
UNITAID can address HCV/HIV co-infection. Lancet (2013) 0.87
Introducing a model of cardiovascular prevention in Nairobi's slums by integrating a public health and private-sector approach: the SCALE-UP study. Glob Health Action (2013) 0.86
The counter effects of the Ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa. AIDS (2016) 0.85
HIV/AIDS prevention and treatment. Lancet (2002) 0.84
Expectations for the United Nations high-level meeting on noncommunicable diseases. Bull World Health Organ (2011) 0.83
Effect of long-cycle structured intermittent versus continuous HAART on quality of life in patients with chronic HIV infection. AIDS (2006) 0.82
Prevention of sexual transmission of HIV: real results, science progressing, societies remaining behind. AIDS (2012) 0.82
A promise to save 100,000 trauma patients. Lancet (2012) 0.81
The evolving HIV/AIDS response and the urgent tasks ahead. Health Aff (Millwood) (2009) 0.80
Game On? Smoking Cessation Through the Gamification of mHealth: A Longitudinal Qualitative Study. JMIR Serious Games (2016) 0.80
"Collateral damages": preparing residents for coping with patient suicide. Acad Psychiatry (2013) 0.79
AIDS is not over. Lancet (2012) 0.79
Informing the 2011 UN Session on Noncommunicable Diseases: applying lessons from the AIDS response. PLoS Med (2011) 0.79
The role of parent characteristics in community-based medication treatment for children with disruptive behavior problems. Community Ment Health J (2012) 0.78
Good politics, bad politics: the experience of AIDS. Am J Public Health (2007) 0.78
Impaired pulmonary blood flow distribution in congestive heart failure assessed using synchrotron radiation microangiography. J Synchrotron Radiat (2013) 0.78
The new age of global health governance holds promise. Nat Med (2010) 0.78
Peter Piot-executive director of UNAIDS. Interview by Pam Das. Lancet Infect Dis (2003) 0.77
Pulmonary vascular tone is dependent on the central modulation of sympathetic nerve activity following chronic intermittent hypoxia. Basic Res Cardiol (2014) 0.76
Condom use by female sex workers and their clients in Mexico: who decides and does it matter? Sex Transm Infect (2011) 0.76
Trends in life expectancy in Europe: one big explanation or many small ones? Eur J Epidemiol (2013) 0.75
Straight talk with ... Peter Piot. Nat Med (2010) 0.75
Increased sympathetic drive during the onset of hypertension in conscious Cyp1a1-Ren2 rats. Pflugers Arch (2013) 0.75
Sustaining treatment costs: who will pay? AIDS (2007) 0.75
HIV/AIDS and human rights: continued commitment in the second decade. Health Hum Rights (1998) 0.75
The changing landscape of global public health. Glob Public Health (2012) 0.75
One-on-one with Dr. Peter Piot. Interview by Charles E. Clifton. Posit Aware (2003) 0.75
["Ebola: a major humanitarian crisis that may linger" (Pr Peter Piot)]. Rev Med Suisse (2014) 0.75
Podcast: 10 questions with Dr. Peter Piot. CMAJ (2015) 0.75